<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03668795</url>
  </required_header>
  <id_info>
    <org_study_id>RoyalMSJordan</org_study_id>
    <nct_id>NCT03668795</nct_id>
  </id_info>
  <brief_title>Surgical Management of Placenta Accreta</brief_title>
  <official_title>Surgical Management of Placenta Accreta a Three Year Experience at King Hussein Medical Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royal Medical Services, Jordanian Armed Forces</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Royal Medical Services, Jordanian Armed Forces</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      purpose of this study was to report our experience for surgical management of suspected
      placenta accreta cases encountered in King Hussein medical center
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      was a retrospective study of all patients who underwent planned deliveries for placenta
      accreta at King Hussein Medical Centre (KHMC) from August 2011 to October 2014.Demographic
      characteristics were recorded. Ultrasound (U/S) and magnetic resonance imaging (MRI) were
      used for the diagnosis. Surgery for all patients were performed by multidisciplinary teams.
      All information were obtained from patient's files.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2011</start_date>
  <completion_date type="Actual">November 30, 2017</completion_date>
  <primary_completion_date type="Actual">October 30, 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The intraoperative and short term postoperative complications of surgical interventions in placenta accreta</measure>
    <time_frame>48 hours</time_frame>
    <description>Intraoperative visceral injuries, bleeding, and short term postoperative morbidity and mortality</description>
  </primary_outcome>
  <enrollment type="Actual">40</enrollment>
  <condition>To Publish Our Experience in the Surgical Management to Placenta Accreta Cases and the Maternal Outcome</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bakrey balloon insertion within the uterus and caesarean hysterectomy</intervention_name>
    <description>Creating an intrauterine tamponade to stop the uterine bleeding by inflating an intrauterine balloon with 600 cc of saline versus undergoing hysterectomy if conservative management failed</description>
    <other_name>Interventional radiological insertion of balloon to obstuct the internal iliac artery</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All pregnant ladies who were diagnosed to have placenta previa accreta cases which was
        diagnosed using ultrasound or MRI
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all placenta previa accreta cases encountered in our institution over three year
             period

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 11, 2018</study_first_submitted>
  <study_first_submitted_qc>September 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2018</study_first_posted>
  <last_update_submitted>September 13, 2018</last_update_submitted>
  <last_update_submitted_qc>September 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Royal Medical Services, Jordanian Armed Forces</investigator_affiliation>
    <investigator_full_name>Mitri Rashed</investigator_full_name>
    <investigator_title>Dr. Mitri Rashed, senior specialist in obstetrics and gynaecology and IVF</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Placenta Accreta</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

